Lemur catta isolate mLemCat1 chromosome 23, mLemCat1.pri, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Strepsirrhini; Lemuriformes; Lemuridae; Lemur.
REFSEQ INFORMATION: The reference sequence is identical to\nCM036494.1.\nAssembly name: mLemCat1.pri\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/11/04. The original whole-genome shotgun project has the\naccession JAJGPY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 16-JUL-2021\nAssembly Method :: hifiasm v. 0.12-r304; purge_dups v.\n 1.2.5; bionano_solve v.\n Solve3.6.1_11162020; salsa2 v. v2.2;\n gEVAL manual curation v. 2021-07-16\nAssembly Name :: mLemCat1.pri\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 20.81x\nSequencing Technology :: Pacbio Sequel II CCS; 10X Genomics linked\n reads; Bionano Genomics DLS; Arima\n Genomics v1 Hi-C\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Lemur catta Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
potassium sodium-activated channel subfamily T member 2
complement factor H-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 181 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
complement factor H-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 200 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
complement factor H-like, transcript variant X1
complement factor H-related protein 2-like, transcript variant X1
complement factor H-related protein 2-like, transcript variant X2
complement factor H-related protein 2-like isoform X1
complement factor H-related protein 2-like isoform X2
zinc finger and BTB domain containing 41, transcript variant X2
zinc finger and BTB domain containing 41, transcript variant X1
zinc finger and BTB domain-containing protein 41
assembly factor for spindle microtubules
abnormal spindle-like microcephaly-associated protein
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 ESTs, 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
crumbs cell polarity complex component 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
DENN domain containing 1B, transcript variant X3
DENN domain containing 1B, transcript variant X1
DENN domain containing 1B, transcript variant X2
DENN domain-containing protein 1B isoform X2
DENN domain-containing protein 1B isoform X1
DENN domain-containing protein 1B isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
COORDINATES: nucleotide motif:Rfam:12.0:RF00069
chromosome 23 C1orf53 homolog, transcript variant X2
chromosome 23 C1orf53 homolog, transcript variant X1
uncharacterized protein C1orf53 homolog isoform X1
uncharacterized protein C1orf53 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 12 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 16 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein tyrosine phosphatase receptor type C, transcript variant X3
protein tyrosine phosphatase receptor type C, transcript variant X2
protein tyrosine phosphatase receptor type C, transcript variant X4
protein tyrosine phosphatase receptor type C, transcript variant X5
protein tyrosine phosphatase receptor type C, transcript variant X6
protein tyrosine phosphatase receptor type C, transcript variant X1
receptor-type tyrosine-protein phosphatase C isoform X1
receptor-type tyrosine-protein phosphatase C isoform X3
receptor-type tyrosine-protein phosphatase C isoform X2
receptor-type tyrosine-protein phosphatase C isoform X4
receptor-type tyrosine-protein phosphatase C isoform X5
receptor-type tyrosine-protein phosphatase C isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00066
nuclear receptor subfamily 5 group A member 2, transcript variant X1
nuclear receptor subfamily 5 group A member 2 isoform X1
nuclear receptor subfamily 5 group A member 2, transcript variant X3
nuclear receptor subfamily 5 group A member 2, transcript variant X2
nuclear receptor subfamily 5 group A member 2 isoform X2
nuclear receptor subfamily 5 group A member 2 isoform X3
uncharacterized LOC123626804, transcript variant X2
uncharacterized LOC123626804, transcript variant X3
uncharacterized LOC123626804, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 ESTs, 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
DEAD-box helicase 59, transcript variant X2
DEAD-box helicase 59, transcript variant X1
probable ATP-dependent RNA helicase DDX59
calmodulin regulated spectrin associated protein family member 2, transcript variant X1
calmodulin regulated spectrin associated protein family member 2, transcript variant X2
calmodulin regulated spectrin associated protein family member 2, transcript variant X3
calmodulin-regulated spectrin-associated protein 2 isoform X1
calmodulin-regulated spectrin-associated protein 2 isoform X2
calmodulin-regulated spectrin-associated protein 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 2 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123626843, transcript variant X3
uncharacterized LOC123626843, transcript variant X6
uncharacterized LOC123626843, transcript variant X4
uncharacterized LOC123626843, transcript variant X5
uncharacterized LOC123626843, transcript variant X1
uncharacterized LOC123626843, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: innate immunity activator protein
kinesin family member 21B, transcript variant X2
kinesin family member 21B, transcript variant X1
kinesin family member 21B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium voltage-gated channel subunit alpha1 S
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 22 Proteins, and 51% coverage of the annotated genomic feature by RNAseq alignments
voltage-dependent L-type calcium channel subunit alpha-1S
achaete-scute family bHLH transcription factor 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
transmembrane protein 9, transcript variant X5
transmembrane protein 9, transcript variant X4
transmembrane protein 9, transcript variant X1
transmembrane protein 9, transcript variant X6
proton-transporting V-type ATPase complex assembly regulator TMEM9 isoform X5
proton-transporting V-type ATPase complex assembly regulator TMEM9 isoform X4
proton-transporting V-type ATPase complex assembly regulator TMEM9 isoform X1
proton-transporting V-type ATPase complex assembly regulator TMEM9 isoform X6
transmembrane protein 9, transcript variant X2
transmembrane protein 9, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
proton-transporting V-type ATPase complex assembly regulator TMEM9 isoform X3
proton-transporting V-type ATPase complex assembly regulator TMEM9 isoform X2
immunoglobulin like and fibronectin type III domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
immunoglobulin-like and fibronectin type III domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 46 ESTs, 8 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
troponin T2, cardiac type, transcript variant X11
troponin T2, cardiac type, transcript variant X12
troponin T2, cardiac type, transcript variant X9
troponin T2, cardiac type, transcript variant X5
troponin T2, cardiac type, transcript variant X8
troponin T2, cardiac type, transcript variant X7
troponin T2, cardiac type, transcript variant X3
troponin T2, cardiac type, transcript variant X4
troponin T2, cardiac type, transcript variant X1
troponin T2, cardiac type, transcript variant X6
troponin T2, cardiac type, transcript variant X2
troponin T2, cardiac type, transcript variant X10
pleckstrin homology like domain family A member 3
pleckstrin homology-like domain family A member 3
neuron navigator 1, transcript variant X1
neuron navigator 1, transcript variant X2
neuron navigator 1, transcript variant X3
neuron navigator 1, transcript variant X4
neuron navigator 1, transcript variant X5
neuron navigator 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 166 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
translocase of inner mitochondrial membrane 17A
mitochondrial import inner membrane translocase subunit Tim17-A
protein tyrosine phosphatase non-receptor type 7, transcript variant X1
protein tyrosine phosphatase non-receptor type 7, transcript variant X6
protein tyrosine phosphatase non-receptor type 7, transcript variant X4
protein tyrosine phosphatase non-receptor type 7, transcript variant X5
protein tyrosine phosphatase non-receptor type 7, transcript variant X3
protein tyrosine phosphatase non-receptor type 7, transcript variant X2
tyrosine-protein phosphatase non-receptor type 7 isoform X1
protein tyrosine phosphatase non-receptor type 7, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 12 ESTs, 13 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
tyrosine-protein phosphatase non-receptor type 7 isoform X3
tyrosine-protein phosphatase non-receptor type 7 isoform X2
receptor-type tyrosine-protein phosphatase V-like
receptor-type tyrosine-protein phosphatase V-like, transcript variant X7
receptor-type tyrosine-protein phosphatase V-like, transcript variant X1
receptor-type tyrosine-protein phosphatase V-like, transcript variant X2
receptor-type tyrosine-protein phosphatase V-like, transcript variant X4
receptor-type tyrosine-protein phosphatase V-like, transcript variant X5
receptor-type tyrosine-protein phosphatase V-like, transcript variant X3
receptor-type tyrosine-protein phosphatase V-like, transcript variant X6
receptor-type tyrosine-protein phosphatase V-like isoform X3
receptor-type tyrosine-protein phosphatase V-like isoform X4
receptor-type tyrosine-protein phosphatase V-like isoform X1
receptor-type tyrosine-protein phosphatase V-like isoform X2
leucine rich repeat containing G protein-coupled receptor 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 14 ESTs, 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine-rich repeat-containing G-protein coupled receptor 6
ubiquitin conjugating enzyme E2 T, transcript variant X1
ubiquitin conjugating enzyme E2 T, transcript variant X2
protein phosphatase 1 regulatory subunit 12B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 32 ESTs, 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein phosphatase 1 regulatory subunit 12B, transcript variant X8
protein phosphatase 1 regulatory subunit 12B, transcript variant X3
protein phosphatase 1 regulatory subunit 12B, transcript variant X5
protein phosphatase 1 regulatory subunit 12B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 32 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein phosphatase 1 regulatory subunit 12B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 32 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein phosphatase 1 regulatory subunit 12B, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 23 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein phosphatase 1 regulatory subunit 12B isoform X3
protein phosphatase 1 regulatory subunit 12B isoform X5
protein phosphatase 1 regulatory subunit 12B isoform X1
protein phosphatase 1 regulatory subunit 12B isoform X2
protein phosphatase 1 regulatory subunit 12B isoform X4
protein phosphatase 1 regulatory subunit 12B isoform X7
protein phosphatase 1 regulatory subunit 12B isoform X8
protein phosphatase 1 regulatory subunit 12B, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein phosphatase 1 regulatory subunit 12B isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 22% coverage of the annotated genomic feature by RNAseq alignments
protein phosphatase 1 regulatory subunit 12B, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
protein phosphatase 1 regulatory subunit 12B isoform X9
protein phosphatase 1 regulatory subunit 12B, transcript variant X10
protein phosphatase 1 regulatory subunit 12B isoform X10
uncharacterized LOC123626961, transcript variant X1
uncharacterized LOC123626961, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 19 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
lysine demethylase 5B, transcript variant X3
lysine demethylase 5B, transcript variant X2
lysine demethylase 5B, transcript variant X1
lysine demethylase 5B, transcript variant X4
lysine-specific demethylase 5B isoform X3
lysine-specific demethylase 5B isoform X1
lysine-specific demethylase 5B isoform X4
lysine-specific demethylase 5B isoform X2
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like protein MGAT4E
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 63% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like protein MGAT4E
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 191 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
kelch like family member 12, transcript variant X1
kelch like family member 12, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
adiponectin receptor 1, transcript variant X1
adiponectin receptor 1, transcript variant X2
adiponectin receptor 1, transcript variant X3
alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 74% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 13% coverage of the annotated genomic feature by RNAseq alignments
transmembrane protein 183A, transcript variant X1
transmembrane protein 183A, transcript variant X2
transmembrane protein 183A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 122 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adenosine A1 receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 81 ESTs, 12 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adenosine A1 receptor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 47 ESTs, 12 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 12 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
proline and arginine rich end leucine rich repeat protein, transcript variant X2
proline and arginine rich end leucine rich repeat protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123626987, transcript variant X2
uncharacterized LOC123626987, transcript variant X1
ATPase plasma membrane Ca2+ transporting 4, transcript variant X2
ATPase plasma membrane Ca2+ transporting 4, transcript variant X3
ATPase plasma membrane Ca2+ transporting 4, transcript variant X1
plasma membrane calcium-transporting ATPase 4 isoform X3
plasma membrane calcium-transporting ATPase 4 isoform X1
plasma membrane calcium-transporting ATPase 4 isoform X2
lymphocyte transmembrane adaptor 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
lymphocyte transmembrane adaptor 1, transcript variant X1
lymphocyte transmembrane adaptor 1, transcript variant X3
lymphocyte transmembrane adaptor 1, transcript variant X2
zinc finger CCCH-type containing 11A, transcript variant X9
zinc finger CCCH-type containing 11A, transcript variant X5
zinc finger CCCH-type containing 11A, transcript variant X7
zinc finger CCCH-type containing 11A, transcript variant X8
zinc finger CCCH-type containing 11A, transcript variant X3
zinc finger CCCH-type containing 11A, transcript variant X1
zinc finger CCCH-type containing 11A, transcript variant X10
zinc finger CCCH-type containing 11A, transcript variant X2
zinc finger CCCH-type containing 11A, transcript variant X6
zinc finger CCCH-type containing 11A, transcript variant X4
zinc finger BED domain-containing protein 6
zinc finger CCCH domain-containing protein 11A
small nuclear ribonucleoprotein polypeptide E
SRY-box transcription factor 13, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 ESTs, 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SRY-box transcription factor 13, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 ESTs, 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SRY-box transcription factor 13, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 ESTs, 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123626780, transcript variant X2
uncharacterized LOC123626780, transcript variant X1
ethanolamine kinase 2, transcript variant X1
ethanolamine kinase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
KiSS-1 metastasis suppressor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
KiSS-1 metastasis suppressor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
KiSS-1 metastasis suppressor, transcript variant X3
pleckstrin homology domain containing A6, transcript variant X4
pleckstrin homology domain containing A6, transcript variant X7
pleckstrin homology domain containing A6, transcript variant X3
pleckstrin homology domain containing A6, transcript variant X6
pleckstrin homology domain containing A6, transcript variant X2
pleckstrin homology domain containing A6, transcript variant X1
pleckstrin homology domain containing A6, transcript variant X11
pleckstrin homology domain containing A6, transcript variant X10
pleckstrin homology domain containing A6, transcript variant X9
pleckstrin homology domain containing A6, transcript variant X14
pleckstrin homology domain containing A6, transcript variant X12
pleckstrin homology domain containing A6, transcript variant X5
pleckstrin homology domain containing A6, transcript variant X8
pleckstrin homology domain containing A6, transcript variant X20
pleckstrin homology domain containing A6, transcript variant X13
pleckstrin homology domain containing A6, transcript variant X19
pleckstrin homology domain containing A6, transcript variant X17
pleckstrin homology domain containing A6, transcript variant X15
pleckstrin homology domain containing A6, transcript variant X18
pleckstrin homology domain containing A6, transcript variant X16
pleckstrin homology domain containing A6, transcript variant X22
pleckstrin homology domain containing A6, transcript variant X21
pleckstrin homology domain-containing family A member 6 isoform X5
pleckstrin homology domain-containing family A member 6 isoform X8
pleckstrin homology domain-containing family A member 6 isoform X4
pleckstrin homology domain-containing family A member 6 isoform X6
pleckstrin homology domain-containing family A member 6 isoform X3
pleckstrin homology domain-containing family A member 6 isoform X1
pleckstrin homology domain-containing family A member 6 isoform X2
pleckstrin homology domain-containing family A member 6 isoform X7
pleckstrin homology domain-containing family A member 6 isoform X9
pleckstrin homology domain-containing family A member 6 isoform X10
pleckstrin homology domain-containing family A member 6 isoform X11
protein phosphatase 1 regulatory subunit 15B, transcript variant X2
protein phosphatase 1 regulatory subunit 15B, transcript variant X1
protein phosphatase 1 regulatory subunit 15B isoform X2
protein phosphatase 1 regulatory subunit 15B isoform X1
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta, transcript variant X2
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta, transcript variant X1
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta, transcript variant X3
phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta isoform X1
phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta isoform X2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
MDM4 regulator of p53, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 93 ESTs, 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
MDM4 regulator of p53, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 69 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
MDM4 regulator of p53, transcript variant X5
MDM4 regulator of p53, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 68 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
MDM4 regulator of p53, transcript variant X6
MDM4 regulator of p53, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 ESTs, 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
MDM4 regulator of p53, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 48 ESTs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
MDM4 regulator of p53, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 35 ESTs, 10 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
small nucleolar RNA SNORA3/SNORA45 family
COORDINATES: nucleotide motif:Rfam:12.0:RF00334
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X7
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X6
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X5
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X2
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 70 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 79 ESTs, 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
retinoblastoma-binding protein 5 isoform X7
retinoblastoma-binding protein 5 isoform X6
retinoblastoma-binding protein 5 isoform X5
retinoblastoma-binding protein 5 isoform X2
retinoblastoma-binding protein 5 isoform X3
retinoblastoma-binding protein 5 isoform X4
retinoblastoma-binding protein 5 isoform X1
dual serine/threonine and tyrosine protein kinase, transcript variant X1
dual serine/threonine and tyrosine protein kinase, transcript variant X2
dual serine/threonine and tyrosine protein kinase isoform X2
dual serine/threonine and tyrosine protein kinase isoform X1
transmembrane and coiled-coil domain family 2, transcript variant X1
transmembrane and coiled-coil domains protein 2 isoform X1
transmembrane and coiled-coil domain family 2, transcript variant X2
transmembrane and coiled-coil domain family 2, transcript variant X3
transmembrane and coiled-coil domains protein 2 isoform X2
transmembrane and coiled-coil domain family 2, transcript variant X4
transmembrane and coiled-coil domains protein 2 isoform X3
kelch domain containing 8A, transcript variant X1
kelch domain containing 8A, transcript variant X2
kelch domain containing 8A, transcript variant X3
kelch domain-containing protein 8A isoform X1
kelch domain-containing protein 8A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 5 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
BLACAT1 overlapping LEMD1 locus, transcript variant X3
BLACAT1 overlapping LEMD1 locus, transcript variant X1
BLACAT1 overlapping LEMD1 locus, transcript variant X2
BLACAT1 overlapping LEMD1 locus, transcript variant X9
BLACAT1 overlapping LEMD1 locus, transcript variant X7
BLACAT1 overlapping LEMD1 locus, transcript variant X6
BLACAT1 overlapping LEMD1 locus, transcript variant X4
BLACAT1 overlapping LEMD1 locus, transcript variant X5
BLACAT1 overlapping LEMD1 locus, transcript variant X10
BLACAT1 overlapping LEMD1 locus, transcript variant X11
BLACAT1 overlapping LEMD1 locus, transcript variant X8
cyclin dependent kinase 18, transcript variant X3
cyclin dependent kinase 18, transcript variant X5
cyclin dependent kinase 18, transcript variant X4
cyclin dependent kinase 18, transcript variant X1
cyclin dependent kinase 18, transcript variant X2
cyclin dependent kinase 18, transcript variant X6
major facilitator superfamily domain containing 4A
major facilitator superfamily domain-containing protein 4A
uncharacterized LOC123627111, transcript variant X1
uncharacterized LOC123627111, transcript variant X2
solute carrier family 45 member 3, transcript variant X16
solute carrier family 45 member 3, transcript variant X7
solute carrier family 45 member 3, transcript variant X2
solute carrier family 45 member 3, transcript variant X3
solute carrier family 45 member 3, transcript variant X4
solute carrier family 45 member 3, transcript variant X13
solute carrier family 45 member 3, transcript variant X10
solute carrier family 45 member 3, transcript variant X5
solute carrier family 45 member 3, transcript variant X11
solute carrier family 45 member 3, transcript variant X8
solute carrier family 45 member 3, transcript variant X1
solute carrier family 45 member 3, transcript variant X6
solute carrier family 45 member 3, transcript variant X12
solute carrier family 45 member 3, transcript variant X9
solute carrier family 45 member 3, transcript variant X15
solute carrier family 45 member 3, transcript variant X14
nuclear casein kinase and cyclin dependent kinase substrate 1, transcript variant X2
nuclear casein kinase and cyclin dependent kinase substrate 1, transcript variant X1
nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 isoform X2
nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00139
RAB29, member RAS oncogene family, transcript variant X3
RAB29, member RAS oncogene family, transcript variant X1
RAB29, member RAS oncogene family, transcript variant X5
RAB29, member RAS oncogene family, transcript variant X4
RAB29, member RAS oncogene family, transcript variant X2
N-fatty-acyl-amino acid synthase/hydrolase PM20D1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RAB7B, member RAS oncogene family, transcript variant X1
RAB7B, member RAS oncogene family, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 71 ESTs, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
regulator of hemoglobinization and erythroid cell expansion
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
regulator of hemoglobinization and erythroid cell expansion protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 3 Proteins
family with sequence similarity 72 member A, transcript variant X3
family with sequence similarity 72 member A, transcript variant X1
family with sequence similarity 72 member A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X1
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X3
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X2
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X4
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 157 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 160 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X7
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X8
SLIT-ROBO Rho GTPase-activating protein 2 isoform X1
SLIT-ROBO Rho GTPase-activating protein 2 isoform X3
SLIT-ROBO Rho GTPase-activating protein 2 isoform X2
SLIT-ROBO Rho GTPase-activating protein 2 isoform X4
SLIT-ROBO Rho GTPase-activating protein 2 isoform X5
SLIT-ROBO Rho GTPase-activating protein 2 isoform X6
SLIT-ROBO Rho GTPase-activating protein 2 isoform X7
SLIT-ROBO Rho GTPase-activating protein 2 isoform X8
inhibitor of nuclear factor kappa B kinase subunit epsilon, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 102 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
inhibitor of nuclear factor kappa B kinase subunit epsilon, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
inhibitor of nuclear factor kappa B kinase subunit epsilon, transcript variant X2
inhibitor of nuclear factor kappa B kinase subunit epsilon, transcript variant X1
inhibitor of nuclear factor kappa B kinase subunit epsilon, transcript variant X3
inhibitor of nuclear factor kappa-B kinase subunit epsilon isoform X1
inhibitor of nuclear factor kappa-B kinase subunit epsilon isoform X2
Ras association domain family member 5, transcript variant X1
Ras association domain family member 5, transcript variant X2
ras association domain-containing protein 5 isoform X1
ras association domain-containing protein 5 isoform X2
Ras association domain family member 5, transcript variant X3
ras association domain-containing protein 5 isoform X3
eukaryotic translation initiation factor 2D, transcript variant X1
eukaryotic translation initiation factor 2D, transcript variant X3
eukaryotic translation initiation factor 2D, transcript variant X2
eukaryotic translation initiation factor 2D isoform X2
eukaryotic translation initiation factor 2D isoform X3
eukaryotic translation initiation factor 2D isoform X1
dual specificity tyrosine phosphorylation regulated kinase 3, transcript variant X1
dual specificity tyrosine-phosphorylation-regulated kinase 3 isoform X1
dual specificity tyrosine phosphorylation regulated kinase 3, transcript variant X2
dual specificity tyrosine-phosphorylation-regulated kinase 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 1 EST, 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123627138, transcript variant X2
uncharacterized LOC123627138, transcript variant X4
uncharacterized LOC123627138, transcript variant X1
uncharacterized LOC123627138, transcript variant X5
uncharacterized LOC123627138, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 11% coverage of the annotated genomic feature by RNAseq alignments
fas apoptotic inhibitory molecule 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fas apoptotic inhibitory molecule 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 89% coverage of the annotated genomic feature by RNAseq alignments
high affinity immunoglobulin alpha and immunoglobulin mu Fc receptor
chromosome 23 C1orf116 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chromosome 23 C1orf116 homolog, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chromosome 23 C1orf116 homolog, transcript variant X6
chromosome 23 C1orf116 homolog, transcript variant X5
chromosome 23 C1orf116 homolog, transcript variant X4
chromosome 23 C1orf116 homolog, transcript variant X2
chromosome 23 C1orf116 homolog, transcript variant X3
chromosome 23 C1orf116 homolog, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chromosome 23 C1orf116 homolog, transcript variant X8
specifically androgen-regulated gene protein isoform X1
specifically androgen-regulated gene protein isoform X2
specifically androgen-regulated gene protein isoform X3
YOD1 deubiquitinase, transcript variant X3
YOD1 deubiquitinase, transcript variant X2
YOD1 deubiquitinase, transcript variant X1
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 ESTs, 37 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X5
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 47 ESTs, 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 mRNAs, 48 ESTs, 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X2
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X2
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X1
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X3
complement component 4 binding protein beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
complement component 4 binding protein beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
C4b-binding protein beta chain isoform X1
C4b-binding protein beta chain isoform X2
complement component 4 binding protein alpha, transcript variant X1
complement component 4 binding protein alpha, transcript variant X2
complement component 4 binding protein alpha, transcript variant X3
complement component 4 binding protein alpha, transcript variant X4
complement component 4 binding protein alpha, transcript variant X5
complement component 4 binding protein alpha, transcript variant X6
CD55 molecule (Cromer blood group), transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
complement decay-accelerating factor isoform X3
CD55 molecule (Cromer blood group), transcript variant X1
CD55 molecule (Cromer blood group), transcript variant X6
CD55 molecule (Cromer blood group), transcript variant X3
CD55 molecule (Cromer blood group), transcript variant X2
CD55 molecule (Cromer blood group), transcript variant X5
CD55 molecule (Cromer blood group), transcript variant X7
CD55 molecule (Cromer blood group), transcript variant X8
complement decay-accelerating factor isoform X6
complement decay-accelerating factor isoform X7
complement decay-accelerating factor isoform X2
complement decay-accelerating factor isoform X1
complement decay-accelerating factor isoform X5
complement decay-accelerating factor isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 7 ESTs, 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
complement C3b/C4b receptor 1 (Knops blood group), transcript variant X2
complement C3b/C4b receptor 1 (Knops blood group), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123626893, transcript variant X2
uncharacterized LOC123626893, transcript variant X3
uncharacterized LOC123626893, transcript variant X4
uncharacterized LOC123626893, transcript variant X1
hematopoietic progenitor cell antigen CD34 isoform X1
hematopoietic progenitor cell antigen CD34 isoform X4
hematopoietic progenitor cell antigen CD34 isoform X3
hematopoietic progenitor cell antigen CD34 isoform X2
uncharacterized LOC123626897, transcript variant X2
uncharacterized LOC123626897, transcript variant X1
uncharacterized LOC123626897, transcript variant X3
uncharacterized LOC123626897, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 38 Proteins, and 53% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 9% coverage of the annotated genomic feature by RNAseq alignments
calcium/calmodulin dependent protein kinase IG
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 18 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
calcium/calmodulin-dependent protein kinase type 1G
laminin subunit beta 3, transcript variant X1
laminin subunit beta 3, transcript variant X2
chromosome 23 C1orf74 homolog, transcript variant X2
chromosome 23 C1orf74 homolog, transcript variant X3
corticosteroid 11-beta-dehydrogenase isozyme 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
TRAF3 interacting protein 3, transcript variant X3
TRAF3 interacting protein 3, transcript variant X1
TRAF3 interacting protein 3, transcript variant X2
TRAF3-interacting JNK-activating modulator isoform X1
TRAF3-interacting JNK-activating modulator isoform X2
chromosome 23 C1orf74 homolog, transcript variant X4
chromosome 23 C1orf74 homolog, transcript variant X1
interferon regulatory factor 6, transcript variant X4
interferon regulatory factor 6, transcript variant X3
interferon regulatory factor 6, transcript variant X1
interferon regulatory factor 6, transcript variant X2
UTP25 small subunit processor component, transcript variant X1
UTP25 small subunit processor component, transcript variant X2
U3 small nucleolar RNA-associated protein 25 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 13 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 3 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
SERTA domain containing 4, transcript variant X1
SERTA domain containing 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 ESTs, 14 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
protein-cysteine N-palmitoyltransferase HHAT
COORDINATES: nucleotide motif:Rfam:12.0:RF00020
potassium voltage-gated channel subfamily H member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 10 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel subfamily H member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel subfamily H member 1 isoform X2
potassium voltage-gated channel subfamily H member 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 21% coverage of the annotated genomic feature by RNAseq alignments
REST corepressor 3, transcript variant X2
REST corepressor 3, transcript variant X6
REST corepressor 3, transcript variant X4
REST corepressor 3, transcript variant X1
REST corepressor 3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
REST corepressor 3, transcript variant X5
REST corepressor 3, transcript variant X3
REST corepressor 3, transcript variant X7
REST corepressor 3, transcript variant X8
TNF receptor associated factor 5, transcript variant X2
TNF receptor associated factor 5, transcript variant X4
TNF receptor associated factor 5, transcript variant X5
TNF receptor associated factor 5, transcript variant X3
TNF receptor associated factor 5, transcript variant X6
TNF receptor associated factor 5, transcript variant X7
TNF receptor associated factor 5, transcript variant X1
TNF receptor-associated factor 5 isoform X1
TNF receptor-associated factor 5 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 9% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
lysophosphatidylglycerol acyltransferase 1, transcript variant X2
lysophosphatidylglycerol acyltransferase 1, transcript variant X5
lysophosphatidylglycerol acyltransferase 1, transcript variant X1
lysophosphatidylglycerol acyltransferase 1, transcript variant X3
acyl-CoA:lysophosphatidylglycerol acyltransferase 1 isoform X1
acyl-CoA:lysophosphatidylglycerol acyltransferase 1 isoform X2
lysophosphatidylglycerol acyltransferase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 ESTs, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
acyl-CoA:lysophosphatidylglycerol acyltransferase 1 isoform X3
uncharacterized LOC123627066, transcript variant X1
uncharacterized LOC123627066, transcript variant X2
integrator complex subunit 7, transcript variant X1
integrator complex subunit 7, transcript variant X2
denticleless E3 ubiquitin protein ligase homolog, transcript variant X1
denticleless E3 ubiquitin protein ligase homolog, transcript variant X2
protein phosphatase 2 regulatory subunit B'alpha, transcript variant X1
protein phosphatase 2 regulatory subunit B'alpha, transcript variant X2
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform isoform X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform isoform X2
proton activated chloride channel 1, transcript variant X1
proton activated chloride channel 1, transcript variant X2
proton-activated chloride channel isoform X1
proton-activated chloride channel isoform X2
proton activated chloride channel 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 ESTs, 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments
proton-activated chloride channel isoform X3
uncharacterized LOC123627072, transcript variant X5
uncharacterized LOC123627072, transcript variant X4
uncharacterized LOC123627072, transcript variant X3
uncharacterized LOC123627072, transcript variant X1
uncharacterized LOC123627072, transcript variant X2
activating transcription factor 3, transcript variant X1
activating transcription factor 3, transcript variant X2
cyclic AMP-dependent transcription factor ATF-3
golgi associated RAB2 interactor family member 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments
basic leucine zipper ATF-like transcription factor 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
basic leucine zipper transcriptional factor ATF-like 3
NSL1 component of MIS12 kinetochore complex
kinetochore-associated protein NSL1 homolog
TatD DNase domain containing 3, transcript variant X1
TatD DNase domain containing 3, transcript variant X2
putative deoxyribonuclease TATDN3 isoform X1
putative deoxyribonuclease TATDN3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 58% coverage of the annotated genomic feature by RNAseq alignments
feline leukemia virus subgroup C receptor-related protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 15 ESTs, 9 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ribosomal protein S6 kinase C1, transcript variant X1
ribosomal protein S6 kinase C1, transcript variant X3
ribosomal protein S6 kinase C1, transcript variant X2
ribosomal protein S6 kinase C1, transcript variant X4
ribosomal protein S6 kinase delta-1 isoform X1
ribosomal protein S6 kinase delta-1 isoform X3
ribosomal protein S6 kinase delta-1 isoform X2
ribosomal protein S6 kinase delta-1 isoform X4
ribosomal protein S6 kinase C1, transcript variant X5
ribosomal protein S6 kinase delta-1 isoform X5
uncharacterized LOC123627085, transcript variant X4
uncharacterized LOC123627085, transcript variant X7
uncharacterized LOC123627085, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123627085, transcript variant X6
uncharacterized LOC123627085, transcript variant X3
uncharacterized LOC123627085, transcript variant X2
uncharacterized LOC123627085, transcript variant X1
prospero homeobox 1, transcript variant X1
prospero homeobox 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
prospero homeobox 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
prospero homeobox 1, transcript variant X2
prospero homeobox 1, transcript variant X4
prospero homeobox 1, transcript variant X3
SET and MYND domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 70 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SET and MYND domain containing 2, transcript variant X1
N-lysine methyltransferase SMYD2 isoform X2
N-lysine methyltransferase SMYD2 isoform X1
SET and MYND domain containing 2, transcript variant X3
N-lysine methyltransferase SMYD2 isoform X3
protein tyrosine phosphatase non-receptor type 14
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 39 ESTs, 7 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LOW QUALITY PROTEIN: tyrosine-protein phosphatase non-receptor type 14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 14% coverage of the annotated genomic feature by RNAseq alignments
potassium two pore domain channel subfamily K member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 1 EST, 17 Proteins, and 31% coverage of the annotated genomic feature by RNAseq alignments
potassium channel subfamily K member 2 isoform X2
potassium two pore domain channel subfamily K member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, 1 EST, 23 Proteins, and 29% coverage of the annotated genomic feature by RNAseq alignments
potassium two pore domain channel subfamily K member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 mRNAs, 1 EST, 17 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
potassium channel subfamily K member 2 isoform X3
potassium channel subfamily K member 2 isoform X1
potassium channel tetramerization domain containing 3, transcript variant X1
potassium channel tetramerization domain containing 3, transcript variant X2
BTB/POZ domain-containing protein KCTD3 isoform X1
BTB/POZ domain-containing protein KCTD3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 28 ESTs, 3 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
G-patch domain containing 2, transcript variant X1
G patch domain-containing protein 2 isoform X1
G-patch domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 116 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
G patch domain-containing protein 2 isoform X2
G-patch domain containing 2, transcript variant X3
G patch domain-containing protein 2 isoform X3
spermatogenesis associated 17, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 27 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
spermatogenesis associated 17, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
transforming growth factor beta 2, transcript variant X1
transforming growth factor beta 2, transcript variant X2
transforming growth factor beta-2 proprotein isoform X1
transforming growth factor beta-2 proprotein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 6% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 30 member 10, transcript variant X1
solute carrier family 30 member 10, transcript variant X2
bifunctional glutamate/proline--tRNA ligase
isoleucyl-tRNA synthetase 2, mitochondrial
COORDINATES: nucleotide motif:Rfam:12.0:RF01210
RAB3 GTPase activating non-catalytic protein subunit 2, transcript variant X1
RAB3 GTPase activating non-catalytic protein subunit 2, transcript variant X2
rab3 GTPase-activating protein non-catalytic subunit isoform X2
rab3 GTPase-activating protein non-catalytic subunit isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00340
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins
microtubule affinity regulating kinase 1, transcript variant X4
microtubule affinity regulating kinase 1, transcript variant X7
microtubule affinity regulating kinase 1, transcript variant X1
microtubule affinity regulating kinase 1, transcript variant X5
microtubule affinity regulating kinase 1, transcript variant X6
microtubule affinity regulating kinase 1, transcript variant X8
microtubule affinity regulating kinase 1, transcript variant X2
microtubule affinity regulating kinase 1, transcript variant X3
serine/threonine-protein kinase MARK1 isoform X1
serine/threonine-protein kinase MARK1 isoform X5
serine/threonine-protein kinase MARK1 isoform X2
serine/threonine-protein kinase MARK1 isoform X6
serine/threonine-protein kinase MARK1 isoform X8
serine/threonine-protein kinase MARK1 isoform X3
serine/threonine-protein kinase MARK1 isoform X4
serine/threonine-protein kinase MARK1 isoform X7
microtubule affinity regulating kinase 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
serine/threonine-protein kinase MARK1 isoform X9
uncharacterized protein C1orf115 homolog
uncharacterized LOC123626903, transcript variant X3
uncharacterized LOC123626903, transcript variant X2
uncharacterized LOC123626903, transcript variant X4
uncharacterized LOC123626903, transcript variant X1
quiescin sulfhydryl oxidase 1, transcript variant X1
quiescin sulfhydryl oxidase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
acyl-CoA-binding domain-containing protein 6
xenotropic and polytropic retrovirus receptor 1
KIAA1614 ortholog, transcript variant X1
KIAA1614 ortholog, transcript variant X2
KIAA1614 ortholog, transcript variant X4
uncharacterized protein KIAA1614 homolog isoform X1
uncharacterized protein KIAA1614 homolog isoform X2
uncharacterized protein KIAA1614 homolog isoform X4
KIAA1614 ortholog, transcript variant X3
uncharacterized protein KIAA1614 homolog isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 70 ESTs, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
major histocompatibility complex class I-related gene protein, transcript variant X2
major histocompatibility complex class I-related gene protein, transcript variant X1
major histocompatibility complex class I-related gene protein, transcript variant X4
major histocompatibility complex class I-related gene protein isoform X1
major histocompatibility complex class I-related gene protein, transcript variant X3
major histocompatibility complex class I-related gene protein isoform X2
major histocompatibility complex class I-related gene protein isoform X3
calcium voltage-gated channel subunit alpha1 E, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 ESTs, 10 Proteins, and 26% coverage of the annotated genomic feature by RNAseq alignments
calcium voltage-gated channel subunit alpha1 E, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 ESTs, 9 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
calcium voltage-gated channel subunit alpha1 E, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 ESTs, 10 Proteins, and 28% coverage of the annotated genomic feature by RNAseq alignments
voltage-dependent R-type calcium channel subunit alpha-1E isoform X2
voltage-dependent R-type calcium channel subunit alpha-1E isoform X3
voltage-dependent R-type calcium channel subunit alpha-1E isoform X1
zinc finger protein 648, transcript variant X1
zinc finger protein 648, transcript variant X2
glutamate-ammonia ligase, transcript variant X1
glutamate-ammonia ligase, transcript variant X2
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: transmembrane epididymal protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
regulator of G-protein signaling protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
regulator of G protein signaling 16, transcript variant X1
regulator of G protein signaling 16, transcript variant X2
regulator of G-protein signaling 16 isoform X2
regulator of G-protein signaling 16 isoform X1
regulator of G protein signaling 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 10 Proteins, and 12% coverage of the annotated genomic feature by RNAseq alignments
regulator of G-protein signaling 8 isoform X1
regulator of G protein signaling 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 14 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
regulator of G-protein signaling 8 isoform X2
uncharacterized LOC123627023, transcript variant X2
uncharacterized LOC123627023, transcript variant X1
N-acetylneuraminate pyruvate lyase, transcript variant X1
N-acetylneuraminate pyruvate lyase, transcript variant X2
N-acetylneuraminate pyruvate lyase, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
N-acetylneuraminate pyruvate lyase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
N-acetylneuraminate pyruvate lyase, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
N-acetylneuraminate pyruvate lyase, transcript variant X3
N-acetylneuraminate pyruvate lyase, transcript variant X4
N-acetylneuraminate pyruvate lyase, transcript variant X5
DExH-box helicase 9, transcript variant X1
DExH-box helicase 9, transcript variant X2
SHC binding and spindle associated 1 like
testicular spindle-associated protein SHCBP1L
nicotinamide nucleotide adenylyltransferase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 103 ESTs, 9 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2
SMG7 nonsense mediated mRNA decay factor, transcript variant X8
SMG7 nonsense mediated mRNA decay factor, transcript variant X1
SMG7 nonsense mediated mRNA decay factor, transcript variant X2
SMG7 nonsense mediated mRNA decay factor, transcript variant X4
SMG7 nonsense mediated mRNA decay factor, transcript variant X5
SMG7 nonsense mediated mRNA decay factor, transcript variant X6
SMG7 nonsense mediated mRNA decay factor, transcript variant X3
SMG7 nonsense mediated mRNA decay factor, transcript variant X7
actin related protein 2/3 complex subunit 5
actin-related protein 2/3 complex subunit 5
small nucleolar RNA SNORA2/SNORA34 family
COORDINATES: nucleotide motif:Rfam:12.0:RF00410
apolipoprotein B mRNA editing enzyme catalytic polypeptide like 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
apolipoprotein B mRNA editing enzyme catalytic polypeptide like 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 18 ESTs, 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ral guanine nucleotide dissociation stimulator like 1, transcript variant X2
ral guanine nucleotide dissociation stimulator like 1, transcript variant X5
ral guanine nucleotide dissociation stimulator-like 1 isoform X5
ral guanine nucleotide dissociation stimulator-like 1 isoform X2
ral guanine nucleotide dissociation stimulator like 1, transcript variant X1
ral guanine nucleotide dissociation stimulator like 1, transcript variant X3
ral guanine nucleotide dissociation stimulator like 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 34 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ral guanine nucleotide dissociation stimulator-like 1 isoform X1
ral guanine nucleotide dissociation stimulator-like 1 isoform X3
ral guanine nucleotide dissociation stimulator-like 1 isoform X4
collagen beta(1-O)galactosyltransferase 2
tRNA splicing endonuclease subunit 15, transcript variant X2
tRNA splicing endonuclease subunit 15, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 ESTs, 3 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tRNA splicing endonuclease subunit 15, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 ESTs, 4 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
tRNA-splicing endonuclease subunit Sen15 isoform X3
tRNA-splicing endonuclease subunit Sen15 isoform X2
tRNA-splicing endonuclease subunit Sen15 isoform X1
chromosome 23 C1orf21 homolog, transcript variant X1
chromosome 23 C1orf21 homolog, transcript variant X3
chromosome 23 C1orf21 homolog, transcript variant X2
ER degradation enhancing alpha-mannosidase like protein 3
ER degradation-enhancing alpha-mannosidase-like protein 3
niban apoptosis regulator 1, transcript variant X1
niban apoptosis regulator 1, transcript variant X2
ring finger protein 2, transcript variant X2
ring finger protein 2, transcript variant X1
E3 ubiquitin-protein ligase RING2 isoform X1
E3 ubiquitin-protein ligase RING2 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00561
tRNA methyltransferase 1 like, transcript variant X3
tRNA methyltransferase 1 like, transcript variant X1
tRNA methyltransferase 1 like, transcript variant X2
SWT1 RNA endoribonuclease homolog, transcript variant X4
SWT1 RNA endoribonuclease homolog, transcript variant X5
SWT1 RNA endoribonuclease homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SWT1 RNA endoribonuclease homolog, transcript variant X2
SWT1 RNA endoribonuclease homolog, transcript variant X1
SWT1 RNA endoribonuclease homolog, transcript variant X6
translocated promoter region, nuclear basket protein, transcript variant X1
translocated promoter region, nuclear basket protein, transcript variant X2
odr-4 GPCR localization factor homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
odr-4 GPCR localization factor homolog, transcript variant X3
odr-4 GPCR localization factor homolog, transcript variant X1
phospholipase A2 group IVA, transcript variant X2
phospholipase A2 group IVA, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 44% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 15 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
BMP/retinoic acid inducible neural specific 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 2 ESTs, 16 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
BMP/retinoic acid inducible neural specific 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 ESTs, 6 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
BMP/retinoic acid-inducible neural-specific protein 3 isoform X1
BMP/retinoic acid-inducible neural-specific protein 3 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00409
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 3 Proteins
COORDINATES: nucleotide motif:Rfam:12.0:RF00271
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 4 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 6% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
ubiquitin C-terminal hydrolase L5, transcript variant X4
ubiquitin C-terminal hydrolase L5, transcript variant X1
ubiquitin C-terminal hydrolase L5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 62 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ubiquitin C-terminal hydrolase L5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase isozyme L5 isoform X1
ubiquitin carboxyl-terminal hydrolase isozyme L5 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF01233
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins
cytochrome b-c1 complex subunit 2, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
bifunctional glutamate/proline--tRNA ligase-like
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
uncharacterized LOC123626883, transcript variant X3
uncharacterized LOC123626883, transcript variant X4
uncharacterized LOC123626883, transcript variant X5
uncharacterized LOC123626883, transcript variant X6
uncharacterized LOC123626883, transcript variant X1
uncharacterized protein LOC123626883 isoform X4
uncharacterized protein LOC123626883 isoform X1
uncharacterized protein LOC123626883 isoform X6
uncharacterized LOC123626883, transcript variant X2
uncharacterized protein LOC123626883 isoform X2
uncharacterized protein LOC123626883 isoform X3
uncharacterized protein LOC123626883 isoform X5
neuroblastoma breakpoint family member 6-like
putative neuroblastoma breakpoint family member 5, transcript variant X1
putative neuroblastoma breakpoint family member 5
putative neuroblastoma breakpoint family member 5, transcript variant X2
putative neuroblastoma breakpoint family member 5, transcript variant X4
putative neuroblastoma breakpoint family member 5, transcript variant X3
putative neuroblastoma breakpoint family member 5, transcript variant X5
uncharacterized LOC123626818, transcript variant X1
uncharacterized LOC123626818, transcript variant X2
uncharacterized LOC123626818, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 62% coverage of the annotated genomic feature by RNAseq alignments